TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation - PubMed (original) (raw)

. 2006 Oct 1;108(7):2307-15.

doi: 10.1182/blood-2006-03-005595. Epub 2006 Jun 15.

Affiliations

• PMID: 16778140
• DOI: 10.1182/blood-2006-03-005595

Free article

TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation

Cheng Qian et al. Blood. 2006.

Free article

Abstract

Regulatory dendritic cells (DCs) play an important role in maintaining peripheral tolerance or immune homeostasis. Our previous study demonstrated that mature DCs could be driven by splenic stroma to proliferate and differentiate into a novel subset of regulatory DCs (diffDCs) displaying a Th2-biased cytokine profile. However, the underlying mechanisms for the unique cytokine profile of diffDCs and how diffDCs regulate the innate and adaptive immunity in response to toll-like receptor (TLR) agonists remain unclear. Here, we report that unlike immature DCs, diffDCs secrete more interleukin 10 (IL-10) but little IL-12p70 in response to lipopolysaccharide (LPS) or other TLR agonists. Up-regulation of extracellular signal-regulated kinase (ERK1/2) activation was shown to be responsible for IL-10 preferential production, and suppression of p38 activation was for impaired IL-12p70 production in diffDCs. Interestingly, LPS treatment could not reverse the inhibitory effect of diffDCs on the proliferation of antigen-specific CD4+ T cells. However, diffDCs could activate natural killer (NK) cells through diffDC-derived IL-10, and even more markedly after stimulation of TLR agonists. These diffDC-activated NK cells could in turn kill surrounding diffDCs. Our results illuminate signal pathways for the unique cytokine profile of diffDCs, and diffDCs can exert their regulatory function even after inflammatory stimuli, thus reflecting one way for strict regulation of immune response.

PubMed Disclaimer

Similar articles

• Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
  Kim WS, Kim H, Kwon KW, Im SH, Lee BR, Ha SJ, Shin SJ. Kim WS, et al. Oncotarget. 2016 Jun 7;7(23):33765-82. doi: 10.18632/oncotarget.9260. Oncotarget. 2016. PMID: 27172902 Free PMC article.
• Metabolic enzyme Suclg2 maintains tolerogenicity of regulatory dendritic cells diffDCs by suppressing Lactb succinylation.
  Zhang X, Liu J, Cheng Y, Chen K, Chen Y, Zhu H, Li Z, Liu S, Cao X. Zhang X, et al. J Autoimmun. 2023 Jul;138:103048. doi: 10.1016/j.jaut.2023.103048. Epub 2023 May 20. J Autoimmun. 2023. PMID: 37216870
• Eicosanoids in the innate immune response: TLR and non-TLR routes.
  Alvarez Y, Valera I, Municio C, Hugo E, Padrón F, Blanco L, Rodríguez M, Fernández N, Crespo MS. Alvarez Y, et al. Mediators Inflamm. 2010;2010:201929. doi: 10.1155/2010/201929. Epub 2010 Jun 15. Mediators Inflamm. 2010. PMID: 20689730 Free PMC article. Review.
• The regulation of IL-10 expression.
  Gabryšová L, Howes A, Saraiva M, O'Garra A. Gabryšová L, et al. Curr Top Microbiol Immunol. 2014;380:157-90. doi: 10.1007/978-3-662-43492-5_8. Curr Top Microbiol Immunol. 2014. PMID: 25004818 Review.

Cited by

• Endocytosis of Mycobacterium tuberculosis heat shock protein 60 is required to induce interleukin-10 production in macrophages.
  Parveen N, Varman R, Nair S, Das G, Ghosh S, Mukhopadhyay S. Parveen N, et al. J Biol Chem. 2013 Aug 23;288(34):24956-71. doi: 10.1074/jbc.M113.461004. Epub 2013 Jul 11. J Biol Chem. 2013. PMID: 23846686 Free PMC article.
• NF-κB, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment.
  Dáňová K, Klapetková A, Kayserová J, Šedivá A, Špíšek R, Jelínková LP. Dáňová K, et al. Oncotarget. 2015 Jun 10;6(16):14123-38. doi: 10.18632/oncotarget.4234. Oncotarget. 2015. PMID: 26053099 Free PMC article.
• Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses.
  Hélie P, Camacho-Toledano C, Lesec L, Seillier C, Miralles AJ, Ortega MC, Guérit S, Lebas H, Bardou I, Vila-Del Sol V, Vivien D, Le Mauff B, Clemente D, Docagne F, Toutirais O. Hélie P, et al. J Neuroinflammation. 2021 Feb 20;18(1):52. doi: 10.1186/s12974-021-02102-5. J Neuroinflammation. 2021. PMID: 33610187 Free PMC article.
• The Role of NK Cells in EBV Infection and EBV-Associated NPC.
  Png YT, Yang AZY, Lee MY, Chua MJM, Lim CM. Png YT, et al. Viruses. 2021 Feb 15;13(2):300. doi: 10.3390/v13020300. Viruses. 2021. PMID: 33671917 Free PMC article. Review.
• OX40 ligand shuts down IL-10-producing regulatory T cells.
  Ito T, Wang YH, Duramad O, Hanabuchi S, Perng OA, Gilliet M, Qin FX, Liu YJ. Ito T, et al. Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13138-43. doi: 10.1073/pnas.0603107103. Epub 2006 Aug 21. Proc Natl Acad Sci U S A. 2006. PMID: 16924108 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Silverchair Information Systems

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal